Cargando…
Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
BACKGROUND: Ipsilateral breast tumor recurrence (IBTR) after partial breast resection and contralateral breast tumor recurrence (CBTR) have been shown to occur relatively frequently in patients with ductal carcinoma in situ (DCIS). However, there is only limited data from Japanese institutes to supp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839035/ https://www.ncbi.nlm.nih.gov/pubmed/25666939 http://dx.doi.org/10.1007/s12282-015-0595-x |
_version_ | 1782428076820398080 |
---|---|
author | Tamura, Nobuko Tsuda, Hitoshi Yoshida, Masayuki Hojo, Takashi Akashi-Tanaka, Sadako Kinoshita, Takayuki Sugihara, Kenichi |
author_facet | Tamura, Nobuko Tsuda, Hitoshi Yoshida, Masayuki Hojo, Takashi Akashi-Tanaka, Sadako Kinoshita, Takayuki Sugihara, Kenichi |
author_sort | Tamura, Nobuko |
collection | PubMed |
description | BACKGROUND: Ipsilateral breast tumor recurrence (IBTR) after partial breast resection and contralateral breast tumor recurrence (CBTR) have been shown to occur relatively frequently in patients with ductal carcinoma in situ (DCIS). However, there is only limited data from Japanese institutes to support this. METHODS: Of 301 consecutive DCIS patients, 179 patients underwent a mastectomy, and the other 122 underwent partial resection in the National Cancer Center Hospital, Tokyo, with a median follow-up period of 2,106 days. We reviewed clinicopathological parameters including age, menopausal status, body mass index, family history (FH) of breast cancer, tumor size, histological subtype, nuclear grade (NG), hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status, treatment, and the surgical margin status of partially resected specimens. The risk associated with each of these parameters for IBTR in 122 patients who underwent partial resections, and for CBTR in a total of 301 patients were calculated using Cox proportional hazard general linear models. RESULTS: Of the 122 patients who underwent partial breast resection, IBTR occurred in 7 (5.7 %). The risk of IBTR was higher or tended to be higher in younger patients or those with lower NG tumors, but did not change significantly with respect to margin status or irradiation. Amongst the entire cohort of 301 patients, CBTR occurred in 18 cases (6.0 %). CBTR occurred significantly more frequently in patients with a FH of breast cancer and with HR+/HER2− subtype tumors by univariate analyses, and tumor subtype was an independent risk factor for CBTR by multivariate analysis. CONCLUSIONS: The local recurrence rate was low following partial resection of DCIS. Younger age was a risk factor for IBTR, whereas the HR+/HER2− tumor subtype and a FH of breast cancer were risk factors for CBTR. |
format | Online Article Text |
id | pubmed-4839035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-48390352016-05-11 Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ Tamura, Nobuko Tsuda, Hitoshi Yoshida, Masayuki Hojo, Takashi Akashi-Tanaka, Sadako Kinoshita, Takayuki Sugihara, Kenichi Breast Cancer Original Article BACKGROUND: Ipsilateral breast tumor recurrence (IBTR) after partial breast resection and contralateral breast tumor recurrence (CBTR) have been shown to occur relatively frequently in patients with ductal carcinoma in situ (DCIS). However, there is only limited data from Japanese institutes to support this. METHODS: Of 301 consecutive DCIS patients, 179 patients underwent a mastectomy, and the other 122 underwent partial resection in the National Cancer Center Hospital, Tokyo, with a median follow-up period of 2,106 days. We reviewed clinicopathological parameters including age, menopausal status, body mass index, family history (FH) of breast cancer, tumor size, histological subtype, nuclear grade (NG), hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status, treatment, and the surgical margin status of partially resected specimens. The risk associated with each of these parameters for IBTR in 122 patients who underwent partial resections, and for CBTR in a total of 301 patients were calculated using Cox proportional hazard general linear models. RESULTS: Of the 122 patients who underwent partial breast resection, IBTR occurred in 7 (5.7 %). The risk of IBTR was higher or tended to be higher in younger patients or those with lower NG tumors, but did not change significantly with respect to margin status or irradiation. Amongst the entire cohort of 301 patients, CBTR occurred in 18 cases (6.0 %). CBTR occurred significantly more frequently in patients with a FH of breast cancer and with HR+/HER2− subtype tumors by univariate analyses, and tumor subtype was an independent risk factor for CBTR by multivariate analysis. CONCLUSIONS: The local recurrence rate was low following partial resection of DCIS. Younger age was a risk factor for IBTR, whereas the HR+/HER2− tumor subtype and a FH of breast cancer were risk factors for CBTR. Springer Japan 2015-02-11 2016 /pmc/articles/PMC4839035/ /pubmed/25666939 http://dx.doi.org/10.1007/s12282-015-0595-x Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Article Tamura, Nobuko Tsuda, Hitoshi Yoshida, Masayuki Hojo, Takashi Akashi-Tanaka, Sadako Kinoshita, Takayuki Sugihara, Kenichi Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ |
title | Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ |
title_full | Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ |
title_fullStr | Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ |
title_full_unstemmed | Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ |
title_short | Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ |
title_sort | clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839035/ https://www.ncbi.nlm.nih.gov/pubmed/25666939 http://dx.doi.org/10.1007/s12282-015-0595-x |
work_keys_str_mv | AT tamuranobuko clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu AT tsudahitoshi clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu AT yoshidamasayuki clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu AT hojotakashi clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu AT akashitanakasadako clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu AT kinoshitatakayuki clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu AT sugiharakenichi clinicopathologicalpredictivefactorsforipsilateralandcontralateraleventsfollowinginitialsurgerytotreatductalcarcinomainsitu |